A clinical analysis of 30 patients with hemophagocytic syndrome

LI Guohui,FAN Yuzhen,HAO Miaowang,HUANG Siyong,LIU Li,YANG Jian,LIANG Yingmin
DOI: https://doi.org/10.3969/j.issn.1004-2806.2011.03.006
2011-01-01
Abstract:Objective:To investigate the clinical features,diagnosis and treatment of hemophagocytic syndrome(HPS) and possible factors affecting prognosis.Method:A retrospective study was carried out to analyze the causes,clinical features,laboratory findings,treatment and clinical outcomes of 30 patients with HPS.Result:Infection was the most common underlying disease(30%),in which EB virus-associated HPS was predominant,accounting for 20%.However,the cause of HPS was unknown in 56.7% patients.HPS was clinically characterized by prolonged fever(100%),splenomegaly(93.3%),Cytopenias(83.3%) and other features including elevated Serum ferritin(100%) and lactate dehydrogenase(100%).Liver dysfunction(90%) and elevated cardiac enzyme levels(60%) were also frequently observed.Overall survival at 30 days,100 days and 1 years was 36.7%,23.3%,10% respectively for all the patients,while the rate was 85.1%,71.4%,42.9% for those using chemotherapy regimens containing etoposide.Conclusion:There are various underlying diseases and clinical manifestations for HPS.Prolonged fever,elevated Serum ferritin and lactate dehydrogenase are sensitive diagnostic indicators of HPS.We conclude that early administration of etoposide is effective in treating patients with HPS.
What problem does this paper attempt to address?